| Year |
Citation |
Score |
| 2011 |
Zhang W, Xia C, Nadas J, Chen W, Gu L, Wang PG. Introduction of aromatic group on 4'-OH of α-GalCer manipulated NKT cell cytokine production. Bioorganic & Medicinal Chemistry. 19: 2767-76. PMID 21439833 DOI: 10.1016/J.Bmc.2010.11.061 |
0.392 |
|
| 2009 |
Xia C, Zhang W, Zhang Y, Chen W, Nadas J, Severin R, Woodward R, Wang B, Wang X, Kronenberg M, Wang PG. The roles of 3' and 4' hydroxy groups in alpha-galactosylceramide stimulation of invariant natural killer T cells. Chemmedchem. 4: 1810-5. PMID 19780098 DOI: 10.1002/Cmdc.200900350 |
0.401 |
|
| 2009 |
Nadas J, Li C, Wang PG. Computational structure activity relationship studies on the CD1d/glycolipid/TCR complex using AMBER and AUTODOCK. Journal of Chemical Information and Modeling. 49: 410-23. PMID 19434842 DOI: 10.1021/Ci8002705 |
0.351 |
|
| 2007 |
Chen W, Xia C, Wang J, Thapa P, Li Y, Talukdar A, Nadas J, Zhang W, Zhou D, Wang PG. Synthesis and structure-activity relationship study of isoglobotrihexosylceramide analogues. The Journal of Organic Chemistry. 72: 9914-23. PMID 18020363 DOI: 10.1021/Jo701539K |
0.403 |
|
| 2007 |
Battisti RF, Zhong Y, Fang L, Gibbs S, Shen J, Nadas J, Zhang G, Sun D. Modifying the sugar moieties of daunorubicin overcomes P-gp-mediated multidrug resistance. Molecular Pharmaceutics. 4: 140-53. PMID 17274671 DOI: 10.1021/Mp060075V |
0.349 |
|
| 2006 |
Nadas J, Sun D. Anthracyclines as effective anticancer drugs. Expert Opinion On Drug Discovery. 1: 549-68. PMID 23506066 DOI: 10.1517/17460441.1.6.549 |
0.333 |
|
| 2006 |
Fang L, Zhang G, Li C, Zheng X, Zhu L, Xiao JJ, Szakacs G, Nadas J, Chan KK, Wang PG, Sun D. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance. Journal of Medicinal Chemistry. 49: 932-41. PMID 16451059 DOI: 10.1021/Jm050800Q |
0.351 |
|
| Show low-probability matches. |